Company / Income Tax
ImmunityBio, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$135.0K
FY2025
5-year range
-$135.0K / $34.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#173 of 204
Health Care
What the data says
ImmunityBio, Inc.'s income tax of -$135,000 is lower than 85% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$2M in FY2020 to $34,000 in FY2022.
Based on SEC 10-K filings.
-$135,000 in FY2025.
Improved from -$40,000 to -$135,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 204This company -$135.0K Sector average $118.7M
▼
-100.1% below sector average
Key checks
Key Insights
- Ranks #173 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2022.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$135.0K | - |
| FY2024 | $0 | +100.0% |
| FY2023 | -$40.0K | -217.6% |
| FY2022 | $34.0K | +132.4% |
| FY2021 | -$105.0K | +94.3% |
| FY2020 | -$1.8M | -1658.1% |
| FY2019 | -$105.0K | +81.6% |
| FY2018 | -$572.0K | -90.0% |
| FY2017 | -$301.0K | -30200.0% |
| FY2016 | $1.0K | +100.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026